Page last updated: 2024-10-25

clofilium and Coronary Disease

clofilium has been researched along with Coronary Disease in 2 studies

clofilium: RN given refers to parent cpd; structure

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gough, WB1
el-Sherif, N1
Kowey, PR1
Friehling, TD1
O'Connor, KM1
Wetstein, L1
Kelliher, GJ1

Other Studies

2 other studies available for clofilium and Coronary Disease

ArticleYear
The differential response of normal and ischaemic Purkinje fibres to clofilium, d-sotalol and bretylium.
    Cardiovascular research, 1989, Volume: 23, Issue:6

    Topics: Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Coronary Disease; Dogs; Heart Conduction Syste

1989
The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
    American heart journal, 1985, Volume: 110, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Bretylium Compounds; Bretylium Tosylate; Cats; Coro

1985